Brief: AC Immune Q3 EPS CHF -0.18
03/11/2023 11:07
Nov 3 (Reuters) - AC Immune Q3 net income CHF -15.143 million. * Q3 operating expenses CHF -15.466 million * Q3 operating income CHF -15.466 million * Q3 pretax profit CHF -15.14 million * Q3 EPS CHF -0.18
Recent news on AC Immune SA
See all newsBrief: Ac Immune To Receive Research Grant From Goradia Family For Development Of Aci-7104 In Parkinson’S Disease
AC Immune Q1 net loss narrows on lower expenses
Brief: AC Immune Announces Amendment To Morphomer ® Tau License And Collaboration Agreement With Lilly
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture